Geographic and age variations in mutational processes in colorectal cancer

Marcos Díaz‐Gay(University of California San Diego), Wellington dos Santos(Centre international de recherche sur le cancer), Sarah Moody(Wellcome Sanger Institute), Mariya Kazachkova(University of California San Diego), Ammal Abbasi(University of California San Diego), Christopher D. Steele(University of California San Diego), Raviteja Vangara(University of California San Diego), S. Senkin(Centre international de recherche sur le cancer), Jingwei Wang(Wellcome Sanger Institute), Stephen Fitzgerald(Wellcome Sanger Institute), Erik N. Bergstrom(University of California San Diego), Azhar Khandekar(University of California San Diego), Burçak Otlu(Middle East Technical University), Behnoush Abedi‐Ardekani(Centre international de recherche sur le cancer), Ana Carolina de Carvalho(Centre international de recherche sur le cancer), Thomas Cattiaux(Centre international de recherche sur le cancer), Ricardo Cortez Cardoso Penha(Centre international de recherche sur le cancer), Valérie Gaborieau(Centre international de recherche sur le cancer), Priscilia Chopard(Centre international de recherche sur le cancer), Christine Carreira(Centre international de recherche sur le cancer), Saamin Cheema(Wellcome Sanger Institute), Calli Latimer(Wellcome Sanger Institute), Jon W. Teague(Wellcome Sanger Institute), Anush Mukeriya(Russian Cancer Research Center NN Blokhin), Давид Заридзе(Russian Cancer Research Center NN Blokhin), Riley Cox(Ontario Institute for Cancer Research), Monique Albert(Ontario Institute for Cancer Research), Larry Phouthavongsy(Ontario Institute for Cancer Research), Steven Gallinger(Lunenfeld-Tanenbaum Research Institute), Reza Malekzadeh(Tehran University of Medical Sciences), Ahmadreza Niavarani(Tehran University of Medical Sciences), Marko Miladinov(University Clinical Centre), Katarina Erić(University Clinical Centre), Saša Milosavljević, Suleeporn Sangrajrang(National Cancer Institute of Thailand), María Paula Curado(AC Camargo Hospital), Samuel Aguiar(AC Camargo Hospital), Rui Manuel Reis(Hospital de Câncer de Barretos), Monise Tadin Reis(Hospital de Câncer de Barretos), Luís Gustavo Capochin Romagnolo(Hospital de Câncer de Barretos), Denise Peixoto Guimarães(Hospital de Câncer de Barretos), Ivana Holcátová(Charles University), Jaroslav Kalvach(Charles University), Carlos Vaccaro(Hospital Italiano de Buenos Aires), Tamara Alejandra Piñero(Hospital Italiano de Buenos Aires), Beata Świątkowska(Nofer Institute of Occupational Medicine), Jolanta Lissowska(National Institute of Oncology), Katarzyna Roszkowska‐Purska(National Institute of Oncology), Antonio Huertas(Terry Fox Research Institute), Tatsuhiro Shibata(The University of Tokyo), Satoshi Shiba, Surasak Sangkhathat(Prince of Songkla University), Taned Chitapanarux(Chiang Mai University), Gholamreza Roshandel(Golestan University), Patrícia Ashton‐Prolla(Universidade Federal do Rio Grande do Sul), Daniel C. Damin(Hospital de Clínicas de Porto Alegre), Francine Hehn de Oliveira(Hospital de Clínicas de Porto Alegre), Laura Humphreys(Wellcome Sanger Institute), Trevor D. Lawley(Wellcome Sanger Institute), Sandra Pérdomo(Centre international de recherche sur le cancer), Michael R. Stratton(Wellcome Sanger Institute), Paul Brennan(Centre international de recherche sur le cancer), Ludmil B. Alexandrov(UC San Diego Health System)
Nature
April 23, 2025
Cited by 109Open Access
Full Text

Abstract

Abstract Incidence rates of colorectal cancer vary geographically and have changed over time 1 . Notably, in the past two decades, the incidence of early-onset colorectal cancer, which affects individuals below 50 years of age, has doubled in many countries 2–5 . The reasons for this increase are unknown. Here we investigate whether mutational processes contribute to geographic and age-related differences by examining 981 colorectal cancer genomes from 11 countries. No major differences were found in microsatellite-unstable cancers, but variations in mutation burden and signatures were observed in the 802 microsatellite-stable cases. Multiple signatures, most with unknown aetiologies, exhibited varying prevalence in Argentina, Brazil, Colombia, Russia and Thailand, indicating geographically diverse levels of mutagenic exposure. Signatures SBS88 and ID18, caused by the bacteria-produced mutagen colibactin 6,7 , had higher mutation loads in countries with higher colorectal cancer incidence rates. SBS88 and ID18 were also enriched in early-onset colorectal cancers, being 3.3 times more common in individuals who were diagnosed before 40 years of age than in those over 70 years of age, and were imprinted early during colorectal cancer development. Colibactin exposure was further linked to APC driver mutations, with ID18 being responsible for about 25% of APC driver indels in colibactin-positive cases. This study reveals geographic and age-related variations in colorectal cancer mutational processes, and suggests that mutagenic exposure to colibactin-producing bacteria in early life may contribute to the increasing incidence of early-onset colorectal cancer.


Related Papers